Fatal Outcome of Pembrolizumab-Related Cytokine Release Syndrome in a Patient With Concurrent Parainfluenza Infection
Pembrolizumab improves response and survival in triple-negative breast cancer; however, severe immune-related adverse effects (irAEs) are concerning. We present a case of a patient with triple-negative breast cancer on neoadjuvant pembrolizumab who developed high fever and chills after the seventh c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2025-02-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2023.1217 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|